Boron Trifluoride Etherate on Silica-A Modified Lewis Acid Reagent (VII). Antitumor Activity of Cannabigerol Against Human Oral Epitheloid Carcinoma Cells

Overview

Journal Arch Pharm Res

Specialty Pharmacology

Date 1999 Jan 6

PMID 9875457

Citations 14

Authors

S H Baek

Y O Kim

J S Kwag

K E Choi

W Y Jung

D S Han

Affiliations

Soon will be listed here.

Abstract

Geraniol (1), olivetol (2), cannabinoids (3 and 4) and 5-fluorouracil (5) were tested for their growth inhibitory effects against human oral epitheloid carcinoma cell lines (KB) and NIH 3T3 fibroblasts using two different 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and sulforhodamine B protein (SRB) assay. Cannabigerol (3) exhibited the highest growth-inhibitory activity against the cancer cell lines.

Citing Articles

In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities.

Laaboudi F, Rejdali M, Amhamdi H, Salhi A, Elyoussfi A, Ahari M Toxicol Rep. 2024; 13:101685.

PMID: 39056093 PMC: 11269304. DOI: 10.1016/j.toxrep.2024.101685.

The Minor Phytocannabinoid Delta-8-Tetrahydrocannabinol Attenuates Collagen-Induced Arthritic Inflammation and Pain-Depressed Behaviors.

Vanegas S, Zaki A, Dealy C, Kinsey S J Pharmacol Exp Ther. 2024; 391(2):222-230.

PMID: 38834355 PMC: 11493440. DOI: 10.1124/jpet.124.002189.

Electrochemical Detection of Olivetol Based on Poly(L-Serine) Film Layered Copper Oxide Modified Carbon Paste Electrode (p-L-Serine/CuO/CPE).

You Z, Zhang Y, Duan S, Liu L Nanomaterials (Basel). 2023; 13(1).

PMID: 36615980 PMC: 9824513. DOI: 10.3390/nano13010070.

Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines.

Lamtha T, Tabtimmai L, Songtawee N, Tansakul N, Choowongkomon K Curr Res Pharmacol Drug Discov. 2022; 3:100132.

PMID: 36568260 PMC: 9780064. DOI: 10.1016/j.crphar.2022.100132.

Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives.

Calapai F, Cardia L, Esposito E, Ammendolia I, Mondello C, Lo Giudice R Evid Based Complement Alternat Med. 2022; 2022:3336516.

PMID: 36397993 PMC: 9666035. DOI: 10.1155/2022/3336516.